These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27444613)
81. Kynurenic acid and 5,7-dichlorokynurenic acids improve social and object recognition in male rats. Hlinák Z; Krejci I Psychopharmacology (Berl); 1995 Aug; 120(4):463-9. PubMed ID: 8539328 [TBL] [Abstract][Full Text] [Related]
82. Overexpression of kynurenic acid and 3-hydroxyanthranilic acid after rat traumatic brain injury. Mangas A; Heredia M; Riolobos A; De la Fuente A; Criado JM; Yajeya J; Geffard M; Coveñas R Eur J Histochem; 2018 Nov; 62(4):. PubMed ID: 30426733 [TBL] [Abstract][Full Text] [Related]
83. Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damage. Bigelman E; Pasmanik-Chor M; Dassa B; Itkin M; Malitsky S; Dorot O; Pichinuk E; Kleinberg Y; Keren G; Entin-Meer M PLoS One; 2023; 18(8):e0275550. PubMed ID: 37616231 [TBL] [Abstract][Full Text] [Related]
84. The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain. Martos D; Lőrinczi B; Szatmári I; Vécsei L; Tanaka M Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542368 [TBL] [Abstract][Full Text] [Related]
86. Kynurenic Acid Accelerates Healing of Corneal Epithelium In Vitro and In Vivo. Matysik-Woźniak A; Turski WA; Turska M; Paduch R; Łańcut M; Piwowarczyk P; Czuczwar M; Rejdak R Pharmaceuticals (Basel); 2021 Jul; 14(8):. PubMed ID: 34451850 [TBL] [Abstract][Full Text] [Related]
87. Kynurenic acid in human saliva--does it influence oral microflora? Kuc D; Rahnama M; Tomaszewski T; Rzeski W; Wejksza K; Urbanik-Sypniewska T; Parada-Turska J; Wielosz M; Turski WA Pharmacol Rep; 2006; 58(3):393-8. PubMed ID: 16845213 [TBL] [Abstract][Full Text] [Related]
88. Development of a new surgical technique to infuse kynurenic acid to optic nerves in chickens for studying loss of myelination. Gurdita A; Kwiecien JM; Choh V Heliyon; 2023 Mar; 9(3):e14361. PubMed ID: 36938412 [TBL] [Abstract][Full Text] [Related]
89. Convenient One-Pot Synthesis of Kynurenic Acid Ethyl Ester and Exploration to Direct Synthesis of Neuroprotective Kynurenic Acid and Amide Derivatives. Verma S; Ambatwar R; Datusalia AK; Khatik GL J Org Chem; 2023 Aug; 88(15):10494-10500. PubMed ID: 37463064 [TBL] [Abstract][Full Text] [Related]
90. Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists. Wyant GA; Yu W; Doulamis IP; Nomoto RS; Saeed MY; Duignan T; McCully JD; Kaelin WG Science; 2022 Aug; 377(6606):621-629. PubMed ID: 35926043 [TBL] [Abstract][Full Text] [Related]
91. Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson's disease models. Chen CM; Huang CY; Lai CH; Chen YC; Hwang YT; Lin CY J Liposome Res; 2024 May; ():1-12. PubMed ID: 38779944 [TBL] [Abstract][Full Text] [Related]
92. Exercised accelerated the production of muscle-derived kynurenic acid in skeletal muscle and alleviated the postmenopausal osteoporosis through the Gpr35/NFκB p65 pathway. Shi T; Shi Y; Gao H; Ma Y; Wang Q; Shen S; Shao X; Gong W; Chen X; Qin J; Wu J; Jiang Q; Xue B J Orthop Translat; 2022 Jul; 35():1-12. PubMed ID: 35846727 [TBL] [Abstract][Full Text] [Related]
93. Effect of a kynurenic acid analog on home-cage activity and body temperature in rats. Kassai F; Kedves R; Gyertyán I; Tuka B; Fülöp F; Toldi J; Lendvai B; Vécsei L Pharmacol Rep; 2015 Dec; 67(6):1188-92. PubMed ID: 26481540 [TBL] [Abstract][Full Text] [Related]
94. Regulation of the rat oligodendroglia cell line OLN-93 by antisense transfection of butyrylcholinesterase. Robitzki A; Döll F; Richter-Landsberg C; Layer PG Glia; 2000 Sep; 31(3):195-205. PubMed ID: 10941146 [TBL] [Abstract][Full Text] [Related]
95. proBDNF inhibits the proliferation and migration of OLN‑93 oligodendrocytes. Liu S; Guo W; Zhou H; Tang L; Feng S; Zhong JH; Zhou XF Mol Med Rep; 2018 Oct; 18(4):3809-3817. PubMed ID: 30132570 [TBL] [Abstract][Full Text] [Related]
96. The effect of kynurenic acid on the synthesis of selected cytokines by murine splenocytes - in vitro and ex vivo studies. Małaczewska J; Siwicki AK; Wójcik RM; Turski WA; Kaczorek E Cent Eur J Immunol; 2016; 41(1):39-46. PubMed ID: 27095921 [TBL] [Abstract][Full Text] [Related]
97. The metabolism of kynurenic acid. II. Tracer experiments on the mechanism of kynurenic acid degradation and glutamic acid synthesis by Pseudomonas extracts. HORIBATA K; TANIUCHI H; TASHIRO M; KUNO S; HAYAISHI O J Biol Chem; 1961 Nov; 236():2991-5. PubMed ID: 14448895 [No Abstract] [Full Text] [Related]
98. KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect. Lőrinczi B; Szatmári I Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769362 [TBL] [Abstract][Full Text] [Related]
99. Studies on the metabolism of kynurenic acid. I. The formation of L-glutamic acid, D- and L-alanine, and acetic acid from kynurenic acid by Pseudomonas extracts. HAYAISHI O; TANIUCHI H; TASHIRO M; KUNO S J Biol Chem; 1961 Sep; 236():2492-7. PubMed ID: 13712440 [No Abstract] [Full Text] [Related]
100. Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats. Zhen D; Ding L; Wang B; Wang X; Hou Y; Ding W; Portha B; Liu J Heliyon; 2023 Jul; 9(7):e17733. PubMed ID: 37424591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]